Cargando…

MFNG is an independent prognostic marker for osteosarcoma

BACKGROUND: Osteosarcoma (OS) has been the most common malignancy of the bone in children and adolescents, and the unsatisfactory prognosis of OS sufferers has long been a hard nut. Here, we delved into the markers with a prognostic value for predicting the prognosis of OS patients. METHODS: The mes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yi, Luo, Lili, Qu, Yuxing, Zhou, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369729/ https://www.ncbi.nlm.nih.gov/pubmed/37496053 http://dx.doi.org/10.1186/s40001-023-01139-x

Ejemplares similares

A pan-cancer analysis revealing the role of LFNG, MFNG and RFNG in tumor prognosis and microenvironment
por: Gong, Xun, et al.
Publicado: (2023)

Upregulated GATA3/miR205-5p Axis Inhibits MFNG Transcription and Reduces the Malignancy of Triple-Negative Breast Cancer
por: Mugisha, Samson, et al.
Publicado: (2022)

FBXW7 Acts as an Independent Prognostic Marker and Inhibits Tumor Growth in Human Osteosarcoma
por: Li, Zhanchun, et al.
Publicado: (2015)

Diagnostic investigations of PLA2G16 and CDH11 expression levels as independent prognostic markers of human osteosarcoma
por: Azarsina, Salman, et al.
Publicado: (2016)

Prognostic factors to survival of patients with chondroblastic osteosarcoma
por: Sun, Hui-Hui, et al.
Publicado: (2018)

miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma
por: Dong, Junbo, et al.
Publicado: (2016)

QPRT Acts as an Independent Prognostic Factor in Invasive Breast Cancer
por: Zhou, Lili, et al.
Publicado: (2022)

Comprehensive Characterization of Prognostic Long Noncoding RNAs in Osteosarcoma
por: Gao, Hua, et al.
Publicado: (2020)

RECK is not an independent prognostic marker for breast cancer
por: Gomes, Luciana R., et al.
Publicado: (2015)

FKBP11 improves the malignant property of osteosarcoma cells and acts as a prognostic factor of osteosarcoma
por: Zeng, Duo, et al.
Publicado: (2023)

Diffusion Kurtosis Imaging as a Prognostic Marker in Osteosarcoma Patients with Preoperative Chemotherapy
por: Liu, Chenglei, et al.
Publicado: (2020)

Expression profile analysis identifies key genes as prognostic markers for metastasis of osteosarcoma
por: Guan, Xiaoqing, et al.
Publicado: (2020)

Role of platelet infiltration as independent prognostic marker for gastric adenocarcinomas
por: Wang, Jing, et al.
Publicado: (2020)

Prognostic significance of modified lung immune prognostic index in osteosarcoma patients
por: He, Xuanhong, et al.
Publicado: (2022)

Lysosomal-Associated Protein Transmembrane 4 Beta-35 Overexpression Is a Novel Independent Prognostic Marker for Gastric Carcinoma
por: Liu, Luying, et al.
Publicado: (2015)

Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma
por: Niu, Junjie, et al.
Publicado: (2016)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2019)

Prognostic analysis of telangiectatic osteosarcoma of the extremities
por: Zhong, Wei, et al.
Publicado: (2023)

Osteosarcoma immune prognostic index can indicate the nature of indeterminate pulmonary nodules and predict the metachronous metastasis in osteosarcoma patients
por: He, Xuanhong, et al.
Publicado: (2022)

Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma
por: Tu, Xiu-Ping, et al.
Publicado: (2015)

Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer
por: Ma, Chengquan, et al.
Publicado: (2016)

Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma
por: He, Xuanhong, et al.
Publicado: (2022)

Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma
por: Chen, Changbao, et al.
Publicado: (2021)

Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
por: Liu, Shengye, et al.
Publicado: (2020)

Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients
por: Ouyang, Zhanbo, et al.
Publicado: (2020)

MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32
por: Kelly, Andrew D, et al.
Publicado: (2013)

DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
por: Olsen, Thale Kristin, et al.
Publicado: (2022)

Apoptosis-related genes-based prognostic signature for osteosarcoma
por: Yang, Fei, et al.
Publicado: (2022)

CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma
por: Agrawal, Shefali, et al.
Publicado: (2007)

DAPK1 as an independent prognostic marker in liver cancer
por: Li, Ling, et al.
Publicado: (2017)

Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
por: Liao, Yunfei, et al.
Publicado: (2017)

Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
por: Bertin, Hélios, et al.
Publicado: (2023)

Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma
por: He, Chuan, et al.
Publicado: (2022)

SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer
por: Bao, Jisheng, et al.
Publicado: (2016)

Corrigendum: Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients
por: Ouyang, Zhanbo, et al.
Publicado: (2021)

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2018)

Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2019)

Identification of Prognostic RBPs in Osteosarcoma
por: Li, Bei, et al.
Publicado: (2021)

Corrigendum: Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma
por: Liu, Shengye, et al.
Publicado: (2021)

The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis
por: Zhang, Chao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u3opa1594vd6if2hucvo92bk89